Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
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
767Qtsvbdxv8xKkE